Clinical Trials and Research News Weekly Roundup | S2 E10

Piedmont Heart Named a Top Research Site in Phase 3 VICTORIA Clinical Trial for Patients with Worsening Chronic Heart Failure.
AHA Awards $2m for Cardiovascular-focused AI & Machine Learning Precision Medicine-based Studies Leveraging AWS Platform.
University of Helsinki Researchers Find a Molecule (BT13) that has Therapeutic Potential Against Parkinson’s Disease.
Reneuron Announces Data from PISCES II Trial of CTX Stem Cell Therapy for Stroke Published in Journal of Neurology, Neurosurgery, and Psychiatry.
Merck Receives Complete Response Letter from US FDA for Supplemental Biologics License Applications (sBLAs) for Keytruda Six-Week Dosing Schedule.
Five Prime Therapeutics Cabiralizumab Plus Opdivo Fails Mid-stage Pancreatic Cancer Trial.
Top Investigator from John Theurer Cancer Center, Hackensack University Medical Center to Study Gene-Therapy Cancer Vaccine in Phase II Trial.
Texas-Based CPRIT Allocates $21M to Texas-based Cancer Investigators & Ventures.
Yale Cancer Center Plays Big Role in Study of Pembrolizumab: May Benefit Some Lung Cancer Patients.
Updates on the Bajakah Tree & Medicinal Claims in Indonesia.
New Carnegie Mellon IoT Privacy Assistant App Empowers Users to “Manage” Ubiquitous Data Collection.
Twitter, Kardashians, and the Democratization of Clinical Debate.
The Discovery of a Gene Offers Promise of Treatment of Autoimmune Diseases.
University of Utah-led Study Reveals Powerful AI-based Technology can Predict Hospitalization for Heart Patients.
NIH-Funded iTHRIV Announces the Funding of Four Health Research Projects in Virginia.

Monash University Investigators One Step Closer To Novel Treatment For MS.


CARDIOVASCULAR 00:32
NEUROLOGICAL 01:31
CANCER 02:39
CONNECTED WORLD 06:01
AUTOIMMUNE 07:11
ARTIFICIAL INTELLIGENCE 07:42
THE WATCHLIST SERIES 08:59